Back to Emergency Medicine
Emergency Medicinev2020Evidence-Based

Quick COVID-19 Severity Index (qCSI)

Predicts 24-hour risk of critical respiratory failure in ED admitted COVID-19 patients. This validated prognostic tool helps identify patients at risk for respiratory decompensation using three simple bedside measurements, enabling early intervention and appropriate resource allocation.

Clinical Input Parameters

breaths/min
Range: 8 — 60 breaths/min
%
Range: 50 — 100 %
L/min
Range: 0 — 15 L/min
Clinical Assessment
Awaiting Parameters
qcsi score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Quick COVID-19 Severity Index (qCSI) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within emergency medicine.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

qCSI Score calculated from respiratory rate, lowest oxygen saturation (in first 4h), and oxygen flow rate using validated prediction model

Clinical Pearls & Practice Notes

  • Simple 3-variable bedside tool for COVID-19 respiratory failure prediction
  • Predicts respiratory failure within 24 hours of ED admission
  • Respiratory failure defined as O2 requirement >10 L/min, high-flow device, NIV, invasive ventilation, or death
  • Uses respiratory rate, lowest O2 saturation in first 4 hours, and current oxygen flow rate
  • Low risk (≤3 points): <5% risk of respiratory failure, suitable for standard ward care
  • Intermediate risk (4-6 points): Enhanced monitoring and higher level of care consideration
  • High risk (≥7 points): Intensive monitoring and preparation for respiratory support
  • Sensitivity 79% and specificity 78% for predicting respiratory decompensation (≤3 score)
  • AUC 0.761 for ICU admission prediction
  • Derived and validated during COVID-19 pandemic in 9-ED health system
  • Study included 1,792 admitted COVID-19 patients with 620 (35%) having respiratory failure
  • Useful for resource allocation and early intervention planning
  • Should be used in conjunction with clinical judgment and COVID-19 protocols
  • Reassess if clinical condition changes significantly
  • Consider local COVID-19 treatment protocols and resource availability

Evidence & Literature Citations

  1. Haimovich AD, Ravindra NG, Stoytchev S, Young HP, Wilson FP, van Dijk D, et al. Development and Validation of the Quick COVID-19 Severity Index: A Prognostic Tool for Early Clinical Decompensation. Ann Emerg Med. 2020 Oct;76(4):442-453. doi: 10.1016/j.annemergmed.2020.07.022.
  2. Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. Intensive Care Med. 2020 Apr;46(4):357-360. doi: 10.1007/s00134-020-05954-2.
  3. Covino M, De Matteis G, Santoro M, Sabia L, Simeoni B, Candelli M, et al. Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years. Geriatr Gerontol Int. 2020 Jul;20(7):704-708. doi: 10.1111/ggi.13960.

Score Interpretation Ranges

Low Risk0 – 3 pts

Low risk for respiratory failure

Intermediate Risk4 – 6 pts

Intermediate risk for respiratory failure

High Risk7 – 12 pts

High risk for respiratory failure

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.